Trademark: 97377332
Word
OPROVDA
Status
Pending
Status Code
731
Status Date
Wednesday, April 10, 2024
Serial Number
97377332
Mark Type
4000
Filing Date
Friday, April 22, 2022
Published for Opposition
Tuesday, March 14, 2023

Trademark Owner History
Global Blood Therapeutics, Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for the treatment of vaso-occlusive crisis; pharmaceutical preparations for the treatment of hematological disorders such as sickle cell disease; pharmaceutical preparations for the treatment of hypoxic and hypoxemic conditions

Trademark Events
Apr 11, 2024
Notice Of Approval Of Extension Request E-Mailed
Apr 10, 2024
Sou Extension 2 Granted
Apr 10, 2024
Sou Extension 2 Filed
Apr 10, 2024
Sou Teas Extension Received
Oct 6, 2023
Notice Of Approval Of Extension Request E-Mailed
Oct 4, 2023
Sou Extension 1 Granted
Oct 4, 2023
Sou Extension 1 Filed
Oct 4, 2023
Sou Teas Extension Received
May 9, 2023
Noa E-Mailed - Sou Required From Applicant
Mar 14, 2023
Official Gazette Publication Confirmation E-Mailed
Mar 14, 2023
Published For Opposition
Feb 22, 2023
Notification Of Notice Of Publication E-Mailed
Feb 9, 2023
Approved For Pub - Principal Register
Feb 9, 2023
Assigned To Examiner
Nov 17, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 17, 2022
Teas Change Of Correspondence Received
Nov 17, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 17, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 17, 2022
Teas Change Of Owner Address Received
Apr 28, 2022
New Application Office Supplied Data Entered
Apr 26, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24